BASAGLAR

This brand name is authorized in Brazil, Canada, Ecuador, Hong Kong, Israel, Singapore, Turkey, United States, South Africa

Active ingredients

The drug BASAGLAR contains one active pharmaceutical ingredient (API):

1 Insulin glargine UNII 2ZM8CX04RZ - INSULIN GLARGINE

Insulin glargine is a human insulin analogue designed to have a low solubility at neutral pH. After injection, the acidic solution is neutralised leading to formation of a precipitate from which small amounts of insulin glargine are continuously released. Read about Insulin glargine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BASAGLAR Solution for injection Kwikpen / Tempo pen	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10AE04	Insulin glargine	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AE Insulins and analogues for injection, long-acting
Discover more medicines within A10AE04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 507617090020007, 507617090020107, 507617090020207, 507617090020307, 507617090020407, 507617090020507, 507617090020607, 507617090020707
Country: CA	Health Products and Food Branch	Identifier(s): 02444844, 02461528
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 55-MBE-0416
Country: HK	Department of Health Drug Office	Identifier(s): 65078, 65079
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7859
Country: SG	Health Sciences Authority	Identifier(s): 15081P, 15082P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699673954318, 8699673954325, 8699673954349, 8699673954363, 8699673954370, 8699673954387, 8699673954417, 8699673954424, 8699673954646
Country: US	FDA, National Drug Code	Identifier(s): 0002-7715, 0002-8214
Country: ZA	Health Products Regulatory Authority	Identifier(s): 49/21.1/0708